Published by Josh White on 20th February 2017
(ShareCast News) - Specialist cancer drug discovery and development business Sareum Holdings announced its half-yearly results for the six months to 31 December on Monday, a period in which it made good progress with its cancer and autoimmune disease research programmes.
URL: http://www.digitallook.com/dl/news/story/25573972/...